543 related articles for article (PubMed ID: 35983412)
21. Penetrance and expressivity of the R858H CACNA1C variant in a five-generation pedigree segregating an arrhythmogenic channelopathy.
Gardner RJM; Crozier IG; Binfield AL; Love DR; Lehnert K; Gibson K; Lintott CJ; Snell RG; Jacobsen JC; Jones PP; Waddell-Smith KE; Kennedy MA; Skinner JR
Mol Genet Genomic Med; 2019 Jan; 7(1):e00476. PubMed ID: 30345660
[TBL] [Abstract][Full Text] [Related]
22. Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death.
Coll M; Pérez-Serra A; Mates J; Del Olmo B; Puigmulé M; Fernandez-Falgueras A; Iglesias A; Picó F; Lopez L; Brugada R; Campuzano O
Biology (Basel); 2017 Dec; 7(1):. PubMed ID: 29278359
[TBL] [Abstract][Full Text] [Related]
23. How Does ADPKD Severity Differ Between Family Members?
Yeung KC; Fryml E; Lanktree MB
Kidney Int Rep; 2024 May; 9(5):1198-1209. PubMed ID: 38707833
[TBL] [Abstract][Full Text] [Related]
24. Using Whole Exome Sequencing to Identify Candidate Genes With Rare Variants In Nonsyndromic Cleft Lip and Palate.
Aylward A; Cai Y; Lee A; Blue E; Rabinowitz D; Haddad J;
Genet Epidemiol; 2016 Jul; 40(5):432-41. PubMed ID: 27229527
[TBL] [Abstract][Full Text] [Related]
25. Polygenic risk alters the penetrance of monogenic kidney disease.
Khan A; Shang N; Nestor JG; Weng C; Hripcsak G; Harris PC; Gharavi AG; Kiryluk K
Nat Commun; 2023 Dec; 14(1):8318. PubMed ID: 38097619
[TBL] [Abstract][Full Text] [Related]
26. Harnessing rare variants in neuropsychiatric and neurodevelopment disorders-a Keystone Symposia report.
Cable J; Purcell RH; Robinson E; Vorstman JAS; Chung WK; Constantino JN; Sanders SJ; Sahin M; Dolmetsch RE; Shah BM; Thurm A; Martin CL; Bearden CE; Mulle JG
Ann N Y Acad Sci; 2021 Dec; 1506(1):5-17. PubMed ID: 34342000
[TBL] [Abstract][Full Text] [Related]
27. Population-Based Penetrance of Deleterious Clinical Variants.
Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
[TBL] [Abstract][Full Text] [Related]
28. Genotype and phenotype correlation in 103 individuals with 2q37 deletion syndrome reveals incomplete penetrance and supports HDAC4 as the primary genetic contributor.
Le TN; Williams SR; Alaimo JT; Elsea SH
Am J Med Genet A; 2019 May; 179(5):782-791. PubMed ID: 30848064
[TBL] [Abstract][Full Text] [Related]
29. Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance.
Woodward KJ; Stampalia J; Vanyai H; Rijhumal H; Potts K; Taylor F; Peverall J; Grumball T; Sivamoorthy S; Alinejad-Rokny H; Wray J; Whitehouse A; Nagarajan L; Scurlock J; Afchani S; Edwards M; Murch A; Beilby J; Baynam G; Kiraly-Borri C; McKenzie F; Heng JIT
Mol Genet Genomic Med; 2019 Feb; 7(2):e00507. PubMed ID: 30614210
[TBL] [Abstract][Full Text] [Related]
30. Ten points to consider when providing genetic counseling for variants of incomplete penetrance and variable expressivity detected in a prenatal setting.
Maya I; Sukenik-Halevy R; Basel-Salmon L; Sagi-Dain L
Acta Obstet Gynecol Scand; 2020 Nov; 99(11):1427-1429. PubMed ID: 33084292
[No Abstract] [Full Text] [Related]
31. The prevalence, penetrance, and expressivity of etiologic
Gowans LJ; Busch TD; Mossey PA; Eshete MA; Adeyemo WL; Aregbesola B; Donkor P; Arthur FK; Agbenorku P; Olutayo J; Twumasi P; Braimah R; Oti AA; Plange-Rhule G; Obiri-Yeboah S; Abate F; Hoyte-Williams PE; Hailu T; Murray JC; Butali A
Mol Genet Genomic Med; 2017 Mar; 5(2):164-171. PubMed ID: 28361103
[TBL] [Abstract][Full Text] [Related]
32. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.
Cooper DN; Krawczak M; Polychronakos C; Tyler-Smith C; Kehrer-Sawatzki H
Hum Genet; 2013 Oct; 132(10):1077-130. PubMed ID: 23820649
[TBL] [Abstract][Full Text] [Related]
33. Incomplete penetrance, variable expressivity, or dosage insensitivity in four families with directly transmitted unbalanced chromosome abnormalities.
Bateman MS; Collinson MN; Bunyan DJ; Collins AL; Duncan P; Firth R; Harrison V; Homfray T; Huang S; Kirk B; Lachlan KL; Maloney VK; Barber JCK
Am J Med Genet A; 2018 Feb; 176(2):319-329. PubMed ID: 29194955
[TBL] [Abstract][Full Text] [Related]
34. Rare penetrant mutations confer severe risk of common diseases.
Fiziev PP; McRae J; Ulirsch JC; Dron JS; Hamp T; Yang Y; Wainschtein P; Ni Z; Schraiber JG; Gao H; Cable D; Field Y; Aguet F; Fasnacht M; Metwally A; Rogers J; Marques-Bonet T; Rehm HL; O'Donnell-Luria A; Khera AV; Farh KK
Science; 2023 Jun; 380(6648):eabo1131. PubMed ID: 37262146
[TBL] [Abstract][Full Text] [Related]
35. Narrowing critical regions and determining penetrance for selected 18q- phenotypes.
Cody JD; Heard PL; Crandall AC; Carter EM; Li J; Hardies LJ; Lancaster J; Perry B; Stratton RF; Sebold C; Schaub RL; Soileau B; Hill A; Hasi M; Fox PT; Hale DE
Am J Med Genet A; 2009 Jul; 149A(7):1421-30. PubMed ID: 19533771
[TBL] [Abstract][Full Text] [Related]
36. Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective.
Pasipoularides A
J Mol Cell Cardiol; 2019 Jan; 126():23-35. PubMed ID: 30423317
[TBL] [Abstract][Full Text] [Related]
37. Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia.
Costantini A; Alm JJ; Tonelli F; Valta H; Huber C; Tran AN; Daponte V; Kirova N; Kwon YU; Bae JY; Chung WY; Tan S; Sznajer Y; Nishimura G; Näreoja T; Warren AJ; Cormier-Daire V; Kim OH; Forlino A; Cho TJ; Mäkitie O
J Bone Miner Res; 2021 Feb; 36(2):283-297. PubMed ID: 32916022
[TBL] [Abstract][Full Text] [Related]
38. How does genetic variation modify ND-CNV phenotypes?
Dinneen TJ; Ghrálaigh FN; Walsh R; Lopez LM; Gallagher L
Trends Genet; 2022 Feb; 38(2):140-151. PubMed ID: 34364706
[TBL] [Abstract][Full Text] [Related]
39. Genomic Autopsy of Sudden Deaths in Young Individuals.
Webster G; Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Vanoye CG; Potet F; Page P; Kearns SD; Pottinger T; White S; Arunkumar P; Olson R; Kofman A; Ibrahim N; Ing A; Brew C; Yap KL; Kadri S; George AL; McNally EM
JAMA Cardiol; 2021 Nov; 6(11):1247-1256. PubMed ID: 34379075
[TBL] [Abstract][Full Text] [Related]
40. LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort.
Usnich T; Vollstedt EJ; Schell N; Skrahina V; Bogdanovic X; Gaber H; Förster TM; Heuer A; Koleva-Alazeh N; Csoti I; Basak AN; Ertan S; Genc G; Bauer P; Lohmann K; Grünewald A; Schymanski EL; Trinh J; Schaake S; Berg D; Gruber D; Isaacson SH; Kühn AA; Mollenhauer B; Pedrosa DJ; Reetz K; Sammler EM; Valente EM; Valzania F; Volkmann J; Zittel S; Brüggemann N; Kasten M; Rolfs A; Klein C;
Front Neurol; 2021; 12():710572. PubMed ID: 34475849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
